Mirati Therapeutics Inc (DELISTED) (MRTX:DL)
58.70
0.00 (0.00%)
USD |
NASDAQ |
Jan 23, 16:00
Mirati Therapeutics Revenue (Quarterly): 16.40M for Sept. 30, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 16.40M |
| June 30, 2023 | 13.69M |
| March 31, 2023 | 7.167M |
| December 31, 2022 | 0.934M |
| September 30, 2022 | 5.431M |
| June 30, 2022 | 5.362M |
| March 31, 2022 | 0.709M |
| December 31, 2021 | 0.299M |
| September 30, 2021 | 71.79M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 1.708M |
| September 30, 2020 | 11.42M |
| June 30, 2020 | |
| March 31, 2020 | 0.267M |
| December 31, 2019 | 0.526M |
| September 30, 2019 | 0.988M |
| June 30, 2019 | 0.577M |
| March 31, 2019 | 1.244M |
| December 31, 2018 | 3.459M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | 9.467M |
| December 31, 2017 | |
| September 30, 2017 |
| Date | Value |
|---|---|
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | 0.4997M |
| September 30, 2011 | 0.0646M |
| June 30, 2011 | 1.315M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.267M
Minimum
Mar 2020
71.79M
Maximum
Sep 2021
10.44M
Average
5.362M
Median
Jun 2022
Revenue (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 11.89B |
| Karuna Therapeutics Inc (DELISTED) | -- |
| Puma Biotechnology Inc | 80.54M |
| NovaBay Pharmaceuticals Inc | 2.441M |
| Palatin Technologies Inc | 0.35M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -161.90M |
| Total Expenses (Quarterly) | 188.45M |
| EPS Diluted (Quarterly) | -2.49 |
| Gross Profit Margin (Quarterly) | 89.71% |
| Profit Margin (Quarterly) | -987.2% |